ALK-Abelló A/S

PINK:AKBLF USA Biotechnology
Market Cap
$4.01 Billion
Market Cap Rank
#4276 Global
#2695 in USA
Share Price
$19.90
Change (1 day)
+0.00%
52-Week Range
$19.90 - $21.35
All Time High
$512.00
About

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for th… Read more

ALK-Abelló A/S (AKBLF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.063x

Based on the latest financial reports, ALK-Abelló A/S (AKBLF) has a cash flow conversion efficiency ratio of 0.063x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($386.00 Million) by net assets ($6.17 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ALK-Abelló A/S - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how ALK-Abelló A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

ALK-Abelló A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ALK-Abelló A/S ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for ALK-Abelló A/S (2005–2024)

The table below shows the annual cash flow conversion efficiency of ALK-Abelló A/S from 2005 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $5.37 Billion $1.21 Billion 0.226x +50.52%
2023-12-31 $4.45 Billion $667.00 Million 0.150x +43.79%
2022-12-31 $3.99 Billion $416.00 Million 0.104x -22.43%
2021-12-31 $3.48 Billion $468.00 Million 0.134x +40.87%
2020-12-31 $3.15 Billion $301.00 Million 0.095x +129.69%
2019-12-31 $3.18 Billion $132.00 Million 0.042x +239.08%
2018-12-31 $3.18 Billion $-95.00 Million -0.030x +74.60%
2017-12-31 $3.29 Billion $-387.00 Million -0.118x -183.50%
2016-12-31 $2.88 Billion $405.00 Million 0.141x +107.61%
2015-12-31 $2.70 Billion $183.00 Million 0.068x -50.09%
2014-12-31 $2.35 Billion $320.00 Million 0.136x +109.40%
2013-12-31 $2.25 Billion $146.00 Million 0.065x +62.94%
2012-12-31 $2.28 Billion $91.00 Million 0.040x -79.97%
2011-12-31 $2.17 Billion $431.00 Million 0.199x +46.48%
2010-12-31 $2.02 Billion $274.00 Million 0.136x +0.68%
2009-12-31 $1.93 Billion $260.00 Million 0.135x +32.86%
2008-12-31 $1.86 Billion $189.00 Million 0.102x -40.78%
2007-12-31 $2.11 Billion $362.00 Million 0.171x +498.19%
2006-12-31 $2.09 Billion $60.00 Million 0.029x +1.65%
2005-12-31 $6.21 Billion $175.00 Million 0.028x --